Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV08
- Pharmacological subgroupV08A
- Chemical subgroupV08AB
- Chemical substanceV08AB05Iopromide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Serbia
ALIMS · 9 registrations
Show all 9United States
FDA · 6 registrations
- Ultravist 30062.3% · injectable · Bayer Hlthcare
- Ultravist 37076.9% · injectable · Bayer Hlthcare
- Ultravist (Pharmacy Bulk)49.9%, 62.3%, 76.9% · injectable · Bayer Hlthcare
- Ultravist 15031.2% · injectable · Bayer Hlthcare
Brazil
Anvisa · 3 registrations
At a glance
- ATC code
- V08AB05
- ATC group
- Various
- Registers
- 9
- Historical lists
- 2
- Registrations
- 42
- With their own page
- 31
- Companies
- 11
All medicines with Iopromide
Human medicines from every register that match Iopromide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
42 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ultravist 300 | United States | 62.3% | injectable | Marketed | Bayer Hlthcare |
| Ultravist 370 | United States | 76.9% | injectable | Marketed | Bayer Hlthcare |
| Ultravist (Pharmacy Bulk) | United States | 49.9%, 62.3%, 76.9% | injectable | Marketed | Bayer Hlthcare |
| Ultravist 300 in Plastic Container | United States | 62.3% | injectable | Not marketed | Bayer Hlthcare |
| Ultravist 150 | United States | 31.2% | injectable | Not marketed | Bayer Hlthcare |
| Ultravist 240 | United States | 49.9% | injectable | Not marketed | Bayer Hlthcare |
| ULTRAVIST 300 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION | Spain | 623,4 mg | solución inyectable y para perfusión | Marketed | Bayer Hispania S.L. |
| ULTRAVIST 370 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION | Spain | 768,86 mg | solución inyectable y para perfusión | Marketed | Bayer Hispania S.L. |
| ULTRAVIST 240 mg /ml, SOLUCION INYECTABLE Y PARA PERFUSION EN VIAL | Spain | 498,7 mg | solución inyectable y para perfusión | Marketed | Bayer Hispania S.L. |
| Ultravist-240 mg/ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Bayer B.V. | |
| Ultravist-300 mg/ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Bayer B.V. | |
| Ultravist-370 mg/ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Bayer B.V. | |
| Ultravist 300 mg/ml otopina za injekciju | Croatia | otopina za injekciju | Marketed | Bayer d.o.o. | |
| Ultravist 370 mg/ml otopina za injekciju | Croatia | otopina za injekciju | Marketed | Bayer d.o.o. | |
| Ultravist 300 | Canada | 62 % | Solution | Marketed | Bayer INC |
| Ultravist 370 | Canada | 77 % | Solution | Marketed | Bayer INC |
| ULTRAVIST 300 INJECTION 300 mg Iodine/ml | Singapore | 300 mg/ml | injection | Authorised | Bayer (South East Asia) Pte LTD |
| ULTRAVIST 370 INJECTION 370 mg Iodine/ml | Singapore | 370 mg/ml | injection | Authorised | Bayer (South East Asia) Pte LTD |
| Ultravist 240 Injection | Taiwan | 注射劑 | Authorised | 台灣拜耳股份有限公司 | |
| Ultravist | Brazil | Authorised | Bayer S.A. | ||
| Ultravist 300 | Taiwan | 注射劑 | Authorised | 台灣拜耳股份有限公司 | |
| Ultravist 370 | Taiwan | 注射劑 | Authorised | 台灣拜耳股份有限公司 | |
| Ultravist® 370 | Serbia | 768.86mg/mL | rastvor za injekciju/infuziju | Authorised | Bayer D.O.O. Beograd |
| Ultravist® 370 | Serbia | 768.86mg/mL | rastvor za injekciju/infuziju | Authorised | Bayer D.O.O. Beograd |
| Ultravist® 370 | Serbia | 768.86mg/mL | rastvor za injekciju/infuziju | Authorised | Bayer D.O.O. Beograd |